Transcript
Speaker: Edison's investment companies team recently published a review on Worldwide Healthcare Trust, ticker WWH, w h specialist investment trust offering diversified exposure to global healthcare. care After a difficult financial year 2025, the trust delivered a meaningful return to form in the financial year 2026, with NAV and share price total returns of 10% and 13.1% respectively, well ahead of the benchmark's 1.8% return.
Speaker: Performance was supported by the manager's continued focus on innovation and growth, particularly through biotechnology and the Trust's proprietary biotech M&A basket, which returned 55.9% in sterling terms.
Speaker: The managers, based at healthcare specialist Orbimed, believe the sector backdrop has improved as US policy uncertainty has eased. Looking ahead, attractive biotech valuations, sustained innovation and large farmers' need to replenish pipelines could continue to support m and a activity and further opportunities for value creation.
